Cargando…

Whistleblowing as an anti-corruption strategy in health and pharmaceutical organizations in low- and middle-income countries: a scoping review

BACKGROUND: Whistleblowing can bring suspected wrongdoing to the attention of someone who is in the position to rectify the problem. Whistleblowing research can help improve effectiveness of anti-corruption efforts in the health sector. OBJECTIVE: The objective of this scoping review is to understan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vian, Taryn, Agnew, Brianna, McInnes, Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661981/ https://www.ncbi.nlm.nih.gov/pubmed/36356311 http://dx.doi.org/10.1080/16549716.2022.2140494

Ejemplares similares

Is paying bribes worthwhile? Corruption and innovation in middle-income countries
por: Iorio, Roberto, et al.
Publicado: (2022)

Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches
por: Vian, Taryn
Publicado: (2020)

Kenny’s Whistleblowing and Stanger’s Whistleblowers
por: Vandekerckhove, Wim
Publicado: (2020)

High Stakes Require More Than Just Talk: What to Do About Corruption in Health Systems: Comment on "We Need to Talk About Corruption in Health Systems"
por: Vian, Taryn
Publicado: (2019)

Does financial inclusion control corruption in upper-middle and lower-middle income countries?
por: Barik, Rajesh, et al.
Publicado: (2022)

Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints
por: Kesselheim, Aaron S., et al.
Publicado: (2011)

Promoting anti-corruption, transparency and accountability to achieve universal health coverage
por: Koller, Theadora, et al.
Publicado: (2020)

Whistleblowers: Incentives, Disincentives, and Protection Strategies
por: Lipman, Frederick
Publicado: (2011)

The sustainable development goals as a framework to combat health-sector corruption
por: Mackey, Tim K, et al.
Publicado: (2018)

The Whistleblowing Guide
por: Kenny, Kate
Publicado: (2019)

The disease of corruption: views on how to fight corruption to advance 21(st) century global health goals
por: Mackey, Tim K., et al.
Publicado: (2016)

The Corporate Whistleblower's Survival Guide
por: Devine, Tom
Publicado: (2011)

Corruption and the Other(s): Scope of Superordinate Identity Matters for Corruption Permissibility
por: Pisor, Anne C., et al.
Publicado: (2015)

Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
por: Menang, Olga, et al.
Publicado: (2023)

Plant NLRs: The Whistleblowers of Plant Immunity
por: van Wersch, Solveig, et al.
Publicado: (2020)

Plant NLRs: The Whistleblowers of Plant Immunity
por: van Wersch, Solveig, et al.
Publicado: (2019)

Epistemic Corruption, the Pharmaceutical Industry, and the Body of Medical Science
por: Sismondo, Sergio
Publicado: (2021)

Why We Whistleblowers Are Passionate in Our Convictions
por: Kruszewski, Stefan P
Publicado: (2005)

Whistleblowing and patient safety during COVID-19
por: Armitage, Richard, et al.
Publicado: (2020)

The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
por: Kohler, Jillian Clare, et al.
Publicado: (2020)

The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia
por: Naher, Nahitun, et al.
Publicado: (2020)

Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
por: Nebot Giralt, Ariadna, et al.
Publicado: (2020)

Health of transgender men in low-income and middle-income countries: a scoping review
por: Scheim, Ayden, et al.
Publicado: (2020)

What Can We Learn from Medical Whistleblowers?
por: Lenzer, Jeanne
Publicado: (2005)

Why PLoS Sponsored a Roundtable of Medical Whistleblowers
Publicado: (2005)

Establishing an anti-doping internal whistleblower policy in China
por: Zhang, Zihao
Publicado: (2018)

The role of whistleblowers in protecting the safety and integrity of the food supply
por: Moy, Gerald G.
Publicado: (2018)

Does Whistleblowing on Tax Evaders Reduce Ingroup Cooperation?
por: Chapkovski, Philipp, et al.
Publicado: (2021)

Correction to: The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia
por: Naher, Nahitun, et al.
Publicado: (2020)

Maternal Healthcare in Low- and Middle-Income Countries: A Scoping Review
por: Kitila, Sena Belina, et al.
Publicado: (2022)

Overuse of medications in low- and middle-income countries: a scoping review
por: Albarqouni, Loai, et al.
Publicado: (2023)

The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries
por: Morgan, Steven G., et al.
Publicado: (2017)

Public-private partnerships to build human capacity in low income countries: findings from the Pfizer program
por: Vian, Taryn, et al.
Publicado: (2007)

Scoping review of research on self-managed medication abortion in low-income and middle-income countries
por: Sorhaindo, Annik, et al.
Publicado: (2021)

Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping review
por: Cleland, Charles R, et al.
Publicado: (2023)

Clinical spine care partnerships between high-income countries and low-and-middle-income countries: A scoping review
por: Lin, Hannah, et al.
Publicado: (2023)

Conspicuous corruption: Evidence at a country level
por: Louridas, Panos, et al.
Publicado: (2021)

Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country
por: Minaei, Hossein, et al.
Publicado: (2019)

Mental Health Problems Among Whistleblowers: A Comparative Study
por: van der Velden, Peter G., et al.
Publicado: (2018)

Clinical governance breakdown: Australian cases of wilful blindness and whistleblowing
por: Cleary, Sonja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f8k4gjimdqpfhf8ac4g5g2qosg